ArticleParasites & vectors2025
High seroprevalence of selected vector-borne pathogens in dogs from Saipan, Northern Mariana Islands.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- High prevalence of gastrointestinal parasites in dogs from Saipan, Northern Mariana Islands, including the zoonotic Ancylostoma ceylanicum.Parasites & vectors · 2026Article
- Global prevalence, diagnostics and epidemiological trends of canine filariosis and associated zoonotic infections (2021-2025): a review.Veterinary research communications · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCanine vector-borne diseases (CVBDs) are illnesses caused by pathogens transmitted by blood-feeding arthropods such as ticks and mosquitoes. Many CVBDs, including dirofilariosis, anaplasmosis, and ehrlichiosis, are globally distributed and may cause a variety of clinical signs in dogs. Several CVBD agents are zoonotic, making epidemiological surveillance a joint veterinary and public health effort. In this study, we determined the seropositivity of four pathogens from dogs on Saipan, Northern Mariana Islands, a US Commonwealth located in the western Pacific Ocean.
methodsBlood samples (n = 443) were collected from client-owned, owner surrendered, and shelter dogs that participated in an island-wide spay-and-neuter event in 2023. All samples were assessed using a commercial, point-of-care enzyme-linked immunosorbent assay (ELISA) test (SNAP
resultsOverall, 66.1% (n = 300/443) of the dogs tested positive for at least one pathogen, with the highest prevalence observed for Ehrlichia spp. (58.0%; n = 246/443), followed by Anaplasma spp. (43.1%; n = 184/443) and D. immitis (14.8%; n = 63/443). Among the dogs with a single pathogen detected (30.9%; n = 137/443), Ehrlichia spp. was most prevalent (64.9%; n = 89/137), followed by Anaplasma spp. (23.3%; n = 32/137) and D. immitis (11.6%; n = 16/137). For co-detection of two or more pathogens (36.7%; n = 163/443), Ehrlichia spp. + Anaplasma spp. presented the highest frequency (70.5%; n = 115/163), followed by Ehrlichia spp. + D. immitis (6.7%; n = 11/163), Anaplasma spp. + D. immitis (3.6%; n = 6/163), and Ehrlichia spp. + Anaplasma spp. + D. immitis (19.0%; n = 31/163). Age (P = < 0.001), residing district (P = 0.001), and ownership status (P = < 0.001) were significantly associated with D. immitis positive status in a univariable analysis. Age (P = < 0.001), residing district (P = 0.177), and ownership status (P = 0.014) were significant in a univariable analysis with Ehrlichia spp. as an outcome. Finally, Anaplasma spp. had a significant association with ownership status (P = < 0.001) as a risk factor in a univariable analysis.
conclusionsThis study shows high seropositivity for CVBPs in a dog population living in a poorly studied area. The results of this study suggest that strategies for the prevention and control of these CVBDs should be reinforced on the Island of Saipan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.